234 related articles for article (PubMed ID: 28063048)
41. CD4+ T cells in lymph nodes of UVB-irradiated mice suppress immune responses to new antigens both in vitro and in vivo.
Gorman S; Tan JW; Yerkovich ST; Finlay-Jones JJ; Hart PH
J Invest Dermatol; 2007 Apr; 127(4):915-24. PubMed ID: 17068476
[TBL] [Abstract][Full Text] [Related]
42. Rapid and Efficient Generation of Regulatory T Cells to Commensal Antigens in the Periphery.
Nutsch K; Chai JN; Ai TL; Russler-Germain E; Feehley T; Nagler CR; Hsieh CS
Cell Rep; 2016 Sep; 17(1):206-220. PubMed ID: 27681432
[TBL] [Abstract][Full Text] [Related]
43. PLGA nanoparticles enhance the expression of retinaldehyde dehydrogenase enzymes in dendritic cells and induce FoxP3(+) T-cells in vitro.
Keijzer C; Spiering R; Silva AL; van Eden W; Jiskoot W; Vervelde L; Broere F
J Control Release; 2013 May; 168(1):35-40. PubMed ID: 23500056
[TBL] [Abstract][Full Text] [Related]
44. Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells.
George Chandy A; Hultkrantz S; Raghavan S; Czerkinsky C; Lebens M; Telemo E; Holmgren J
Immunology; 2006 Jul; 118(3):311-20. PubMed ID: 16827892
[TBL] [Abstract][Full Text] [Related]
45. High TCR diversity ensures optimal function and homeostasis of Foxp3+ regulatory T cells.
Föhse L; Suffner J; Suhre K; Wahl B; Lindner C; Lee CW; Schmitz S; Haas JD; Lamprecht S; Koenecke C; Bleich A; Hämmerling GJ; Malissen B; Suerbaum S; Förster R; Prinz I
Eur J Immunol; 2011 Nov; 41(11):3101-13. PubMed ID: 21932448
[TBL] [Abstract][Full Text] [Related]
46. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
Elinav E; Waks T; Eshhar Z
Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
[TBL] [Abstract][Full Text] [Related]
47. Steady state migratory RelB+ langerin+ dermal dendritic cells mediate peripheral induction of antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells.
Azukizawa H; Döhler A; Kanazawa N; Nayak A; Lipp M; Malissen B; Autenrieth I; Katayama I; Riemann M; Weih F; Berberich-Siebelt F; Lutz MB
Eur J Immunol; 2011 May; 41(5):1420-34. PubMed ID: 21469094
[TBL] [Abstract][Full Text] [Related]
48. Distinct modes of antigen presentation promote the formation, differentiation, and activity of foxp3+ regulatory T cells in vivo.
Weissler KA; Garcia V; Kropf E; Aitken M; Bedoya F; Wolf AI; Erikson J; Caton AJ
J Immunol; 2015 Apr; 194(8):3784-97. PubMed ID: 25780041
[TBL] [Abstract][Full Text] [Related]
49. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo.
Gottschalk RA; Corse E; Allison JP
J Exp Med; 2010 Aug; 207(8):1701-11. PubMed ID: 20660617
[TBL] [Abstract][Full Text] [Related]
50. Sublingual 'oral tolerance' induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells.
Sun JB; Czerkinsky C; Holmgren J
Scand J Immunol; 2007; 66(2-3):278-86. PubMed ID: 17635805
[TBL] [Abstract][Full Text] [Related]
51. High TCR stimuli prevent induced regulatory T cell differentiation in a NF-κB-dependent manner.
Molinero LL; Miller ML; Evaristo C; Alegre ML
J Immunol; 2011 Apr; 186(8):4609-17. PubMed ID: 21411734
[TBL] [Abstract][Full Text] [Related]
52. Revealing the in vivo behavior of CD4+ T cells specific for an antigen expressed in Escherichia coli.
Chen ZM; Jenkins MK
J Immunol; 1998 Apr; 160(7):3462-70. PubMed ID: 9531307
[TBL] [Abstract][Full Text] [Related]
53. Oral CD103
Tanaka Y; Nagashima H; Bando K; Lu L; Ozaki A; Morita Y; Fukumoto S; Ishii N; Sugawara S
Mucosal Immunol; 2017 Jan; 10(1):79-90. PubMed ID: 27166558
[TBL] [Abstract][Full Text] [Related]
54. DNA methylation controls Foxp3 gene expression.
Polansky JK; Kretschmer K; Freyer J; Floess S; Garbe A; Baron U; Olek S; Hamann A; von Boehmer H; Huehn J
Eur J Immunol; 2008 Jun; 38(6):1654-63. PubMed ID: 18493985
[TBL] [Abstract][Full Text] [Related]
55. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta.
Selvaraj RK; Geiger TL
J Immunol; 2007 Jul; 179(2):11 p following 1390. PubMed ID: 17695668
[TBL] [Abstract][Full Text] [Related]
56. CD4+CD25+Foxp3+ regulatory T cells are dispensable for controlling CD8+ T cell-mediated lung inflammation.
Tosiek MJ; Gruber AD; Bader SR; Mauel S; Hoymann HG; Prettin S; Tschernig T; Buer J; Gereke M; Bruder D
J Immunol; 2011 Jun; 186(11):6106-18. PubMed ID: 21518973
[TBL] [Abstract][Full Text] [Related]
57. CD4⁺ T-cell immunity in the female genital tract is critically dependent on local mucosal immunization.
Marks E; Helgeby A; Andersson JO; Schön K; Lycke NY
Eur J Immunol; 2011 Sep; 41(9):2642-53. PubMed ID: 21681740
[TBL] [Abstract][Full Text] [Related]
58. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
[TBL] [Abstract][Full Text] [Related]
59. Murine regulatory T cells differ from conventional T cells in resisting the CTLA-4 reversal of TCR stop-signal.
Lu Y; Schneider H; Rudd CE
Blood; 2012 Nov; 120(23):4560-70. PubMed ID: 23047820
[TBL] [Abstract][Full Text] [Related]
60. Daily subcutaneous injections of peptide induce CD4+ CD25+ T regulatory cells.
Dahlberg PE; Schartner JM; Timmel A; Seroogy CM
Clin Exp Immunol; 2007 Aug; 149(2):226-34. PubMed ID: 17490400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
